Published in Medical Letter on the CDC and FDA, August 9th, 1999
Interim results from the study, sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), demonstrate that a single oral dose of the antiretroviral drug nevirapine (NVP) given to an HIV infected woman in labor and another to her baby within three days of birth reduces the transmission rate by half compared to a similar short-course of AZT.
If implemented widely in developing countries, this intervention...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.